DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Trex1 is an exonuclease that degrades cytosolic DNA and has been associated with modulation of interferon responses in autoimmunity and viral infections. Here, the authors show that Trex1 attenuates the immunogenicity of cancer cells treated with high radiation doses by degrading cytosolic DNA and p...
Guardado en:
Autores principales: | Claire Vanpouille-Box, Amandine Alard, Molykutty J. Aryankalayil, Yasmeen Sarfraz, Julie M. Diamond, Robert J. Schneider, Giorgio Inghirami, C. Norman Coleman, Silvia C. Formenti, Sandra Demaria |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fbe7810370734d60b0bb36cf8cb9767e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment
por: RaeAnna Wilson, et al.
Publicado: (2016) -
Nucleoporin TPR is an integral component of the TREX-2 mRNA export pathway
por: Vasilisa Aksenova, et al.
Publicado: (2020) -
Temporal determinants of tumour response to neoadjuvant rectal radiotherapy.
por: Kendrick Koo, et al.
Publicado: (2021) -
The THO/TREX Complex Active in Alternative Splicing Mediates Plant Responses to Salicylic Acid and Jasmonic Acid
por: Nengxu Sun, et al.
Publicado: (2021) -
The mitochondrial outer-membrane location of the EXD2 exonuclease contradicts its direct role in nuclear DNA repair
por: Fenna Hensen, et al.
Publicado: (2018)